Ftse Mib
36.371,67
0,00%
DAX
21.637,53
0,93%
S&P 500
6.039,31
-0,47%
NASDAQ
19.632,32
-0,51%
Bitcoin
105.225,45
1,43%
Pepperstone
Advertisement
Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ GlucoTrack Inc (GCTK) GlucoTrack Inc (GCTK) Notizie

GlucoTrack Inc

GCTK
0,0949
0,0037 (4,06%)
30 Gen 2025 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
29/1/202515:28EDGAR2Form 8-K - Current report
29/1/202515:00GLOBEGlucotrack Strengthens Leadership Team with Appointment of..
21/1/202515:15EDGAR2Form 8-K - Current report
21/1/202514:01GLOBEGlucotrack Announces ISO 13485:2016 Certification
15/1/202514:01GLOBEGlucotrack Strenghtens Leadership Team with Addition of..
14/1/202513:50EDGAR2Form 8-K/A - Current report: [Amend]
13/1/202523:29EDGAR2Form 8-K - Current report
07/1/202522:05GLOBEGlucotrack to Present at TechBio Showcase™ 2025
03/1/202519:38EDGAR2Form SCHEDULE 13G/A - Statement of Beneficial Ownership by..
31/12/202423:00EDGAR2Form 8-K - Current report
17/12/202423:29EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
17/12/202423:27EDGAR2Form 8-K - Current report
06/12/202423:03EDGAR2Form DEF 14A - Other definitive proxy statements
03/12/202415:15EDGAR2Form 8-K - Current report
03/12/202414:30GLOBEGLUCOTRACK ANNOUNCES START OF ENROLLMENT FOR HUMAN CLINICAL..
22/11/202423:15EDGAR2Form PRE 14A - Other preliminary proxy statements
22/11/202422:09EDGAR2Form 3 - Initial statement of beneficial ownership of..
18/11/202423:05EDGAR2Form 8-K - Current report
14/11/202422:42EDGAR2Form 8-K - Current report
14/11/202422:30GLOBEGlucotrack, Inc. Announces Closing of $10.0 Million Public..
14/11/202414:23EDGAR2Form 424B4 - Prospectus [Rule 424(b)(4)]
13/11/202415:14EDGAR2Form 8-K - Current report
13/11/202415:00GLOBEGlucotrack, Inc. Announces Pricing of $10.0 Million Public..
08/11/202423:26EDGAR2Form S-1/A - General form for registration of securities..
08/11/202415:30EDGAR2Form S-1/A - General form for registration of securities..
04/11/202412:27EDGAR2Form S-1/A - General form for registration of securities..
24/10/202422:06EDGAR2Form S-1/A - General form for registration of securities..
22/10/202415:18EDGAR2Form 8-K - Current report
22/10/202415:00GLOBEGLUCOTRACK TO PRESENT AT 2024 BIOFUTURE CONFERENCE
01/10/202415:15EDGAR2Form 8-K - Current report
01/10/202415:00GLOBEGLUCOTRACK ANNOUNCES ORAL & POSTER PRESENTATIONS AT THE 2024..
30/9/202422:14EDGAR2Form S-3/A - Registration statement under Securities Act of..
26/9/202423:14EDGAR2Form 8-K - Current report
23/9/202423:25EDGAR2Form S-3 - Registration statement under Securities Act of..
16/9/202423:26EDGAR2Form S-1 - General form for registration of securities under..
10/9/202422:15EDGAR2Form 8-K - Current report
03/9/202415:15EDGAR2Form 8-K - Current report
03/9/202415:00GLOBEJOHN BALLANTYNE, FORMER BIOTECHNOLOGY EXECUTIVE, JOINS THE..
27/8/202415:12EDGAR2Form 8-K - Current report
27/8/202415:00GLOBEGLUCOTRACK ANNOUNCES NEW VICE PRESIDENT OF CLINICAL..
19/8/202423:22EDGAR2Form DEF 14A - Other definitive proxy statements
15/8/202415:28EDGAR2Form 8-K - Current report
15/8/202415:00GLOBEGlucotrack’s Innovative Blood Glucose Monitoring Concept..
13/8/202422:06EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/8/202422:47EDGAR2Form PRE 14A - Other preliminary proxy statements
05/8/202415:29EDGAR2Form 8-K - Current report
05/8/202415:00GLOBEGLUCOTRACK ANNOUNCES POSTER PRESENTATION ON CONTINUOUS BLOOD..
31/7/202423:15EDGAR2Form 8-K - Current report
31/7/202422:00GLOBEGLUCOTRACK ANNOUNCES NEW FUNDING FOR DEVELOPMENT OF ITS..
22/7/202414:15EDGAR2Form 8-K - Current report
Apertura: 0,092 Min: 0,0909 Max: 0,1115
Chiusura: 0,0912

La tua Cronologia

NASDAQ
GCTK
GlucoTrack
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci